Get the Stockscreener App
8.7889
5.00%
0.4189
Precipio Inc stock is traded at $8.7889, with a volume of 13,256.
It is up +5.00% in the last 24 hours and up +49.47% over the past month.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
See More
Previous Close:
$8.37
Open:
$8.388
24h Volume:
13,256
Relative Volume:
1.10
Market Cap:
$13.58M
Revenue:
$15.81M
Net Income/Loss:
$-4.90M
P/E Ratio:
-2.5699
EPS:
-3.42
Net Cash Flow:
$-2.65M
1W Performance:
+25.56%
1M Performance:
+49.47%
6M Performance:
+46.48%
1Y Performance:
+46.48%
1-Day Range:
$7.52
$9.50
1-Week Range:
$6.7844
$9.50
52-Week Range:
$3.90
$10.74
Precipio Inc Stock (PRPO) Company Profile
Name
Precipio Inc
Sector
Industry
Phone
203 787 7888
Address
12325 EMMET ST, OMAHA, CT
Compare PRPO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
8.9917 | 9.53M | 15.81M | -4.90M | -2.65M | -3.42 |
|
TMO
Thermo Fisher Scientific Inc
|
411.97 | 163.30B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.82 | 143.73B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
517.09 | 40.98B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
113.65 | 32.94B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.60 | 27.01B | 15.50B | 1.33B | 2.16B | 7.34 |
Precipio Inc Stock (PRPO) Latest News
Precipio anticipates return to positive cash flow in Q2 or Q3 2025 amid robust margin gains and regulatory milestones - MSN
Precipio, Inc. (NASDAQ:PRPO) Q1 2025 Earnings Call Transcript - Insider Monkey
(PRPO) Proactive Strategies - news.stocktradersdaily.com
Precipio, Inc. (NASDAQ:PRPO) Q4 2024 Earnings Call Transcript - MSN
Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... - Yahoo Finance
Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational Efficiency Amid Seasonal Challenges - GuruFocus
Precipio Reports Strong Q1-2025 Revenue Growth - TipRanks
Earnings call transcript: Precipio’s Q1 2025 shows revenue growth and stock surge - Investing.com Nigeria
Precipio Inc Reports Q1 2025 Revenue of $4.9 Million and Improved Operational Efficiency - GuruFocus
Precipio Announces its Q1-2025 Financial Results | PRPO Stock Ne - GuruFocus
Precipio Earnings Report: Cancer Diagnostics Leader Posts 43% Revenue Growth, Targets Positive Cash Flow - Stock Titan
Precipio Announces its Q1-2025 Financial Results | PRPO Stock News - GuruFocus
Precipio, Inc. Reports Strong Q1-2025 Financial Performance with 43% Revenue Growth - Nasdaq
Precipio Announces Its Q1-2025 Financial Results - marketscreener.com
Precipio Announces its Q1-2025 Financial Results - GlobeNewswire
Precipio Announces its Q1-2025 Financial Results - GlobeNewswire Inc.
Precipio, Inc. SEC 10-Q Report - TradingView
Precipio announces executive option grants tied to stock performance - MSN
Renaissance Technologies LLC Invests $56,000 in Precipio, Inc. (NASDAQ:PRPO) - Defense World
Precipio Schedules Q1-2025 Shareholder Update Call - TipRanks
Precipio Announces Q1-2025 Shareholder Update Call | PRPO Stock News - GuruFocus
Precipio, Inc. (NASDAQ:PRPO) Short Interest Update - Defense World
Precipio Announces Q1-2025 Shareholder Update Call - The Globe and Mail
Cancer Diagnostics Leader Precipio Sets Q1 2025 Earnings Call: How to Join Live Update - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Precipio (NASDAQ:PRPO) Shares Cross Below 200-Day Moving Average – Should You Sell? - Defense World
The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio - Yahoo
Trading (PRPO) With Integrated Risk Controls - news.stocktradersdaily.com
Precipio Appoints CBIZ as New Auditor Following Marcum Resignation By Investing.com - Investing.com Canada
Precipio Appoints CBIZ as New Auditor Following Marcum Resignation - Investing.com Australia
When (PRPO) Moves Investors should Listen - news.stocktradersdaily.com
Precipio COO Ahmed Zaki Sabet acquires shares worth $473 By Investing.com - Investing.com India
Precipio COO Ahmed Zaki Sabet acquires shares worth $473 - Investing.com
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... - Yahoo
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth Initiatives Unveiled - GuruFocus
Precipio’s Earnings Call: Growth Amid Challenges - TipRanks
Precipio Reports Positive Q4 Financial Results - TipRanks
Earnings call transcript: Precipio Q4 2024 sees revenue growth, strategic shifts - Investing.com India
Precipio Full Year 2024 Earnings: US$2.93 loss per share (vs US$4.51 loss in FY 2023) - Yahoo
Precipio Inc. (PRPO) reports earnings - qz.com
Precipio Announces Q4 and year-end 2024 Shareholder Update Call - The Manila Times
Precipio, Inc. to Host Q4 and Year-End 2024 Corporate Update Call on March 31, 2025 - Nasdaq
Precipio to Reveal Full Year Performance: Key Updates Coming March 31 - StockTitan
(PRPO) Trading Advice - Stock Traders Daily
Precipio (NASDAQ:PRPO) Stock Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World
Precipio, Inc. to Host Earnings Call - ACCESS Newswire
Objective long/short (PRPO) Report - news.stocktradersdaily.com
Precipio (NASDAQ:PRPO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Precipio Re-Launches All CLIA Lab and Pharmacological Research Projects at its New Haven, CT Facility - ACCESS Newswire
Precipio Inc Stock (PRPO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.13%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):